A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease -- aortic stenosis (AS).
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis • The investigational transcatheter aortic valve implantation (TAVI) system will ...
marked a significant milestone with the launch of its Myval Octapro Transcatheter Heart Valve (THV) at GISE 2024 (National Congress of the Italian Society of Interventional Cardiology) and PCR London ...
Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first patient procedures with a yet-unnamed transcatheter aortic valve ...